PII-19KCNMB1 genotype associated with cardiovascular outcomes in the international verapamil SR/trandolapril study (INVEST)

Amber L. Beitelshees,Yan Gong,Rhonda M. Cooper-DeHoff,L. Burt,L. A. Stauffer,C.J. Pepine,Julie A. Johnson

PII-19KCNMB1 genotype associated with cardiovascular outcomes in the international verapamil SR/trandolapril study (INVEST)

2006

Amber L. Beitelshees
Yan Gong
Rhonda M. Cooper-DeHoff
L. Burt
L. A. Stauffer
C.J. Pepine
Julie A. Johnson

Background: Glu65Lys in KCNMB1 has been found to have functional and clinical significance. We tested whether Glu65Lys or Val110Leu were associated with cardiovascular (CV) outcomes (death, nonfatal myocardial infarction (MI) or nonfatal stroke) in a substudy of INVEST.

Keywords:

Myocardial infarction
Diabetes mellitus
Trandolapril
Verapamil SR
Genotype
Clinical significance
Stroke
Medicine
Cardiology
Internal medicine
nonfatal stroke
cardiovascular outcomes

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations